Pharmaceutical Technology's In the Lab eNewsletter, September 2021

The pH effect encountered with oral oncology medication can be overcome with amorphous solid dispersions.

It is important to use correct organization and appropriate methods for demonstrating biosimilar comparability to support regulatory filings.

The University of Southern California and Amgen have teamed up to provide researchers access to two of Thermo Fisher Scientific’s cryo-EM instruments.

A new membrane staining kit, ExoBrite, launched by Biotium aims to enhance the detection of exosomes through flow cytometry.

Eli Lilly and Company and industry partners, including Ziath, are focused on speeding up the drug discovery process with a fully automated lab.

BioMed X has partnered with Janssen to start two new research programs for autoimmune diseases and drug delivery.

BioAgilytix, a US-based contract research laboratory focused on large-molecule drug development, has agreed to purchase 360biolabs, an Australia-based contract research organization specializing in virology and immunology.

Promega will demonstrate applications of bioluminescence tools at Discover Glo 2021.

Todos Medical has completed validation of its cPass neutralizing antibody blood test to monitor COVID-19 immunity.

A new method developed by the NIH bypasses genetic RNA extraction, simplifying the testing process.

The guidance aids in the development, validation, and use of near infrared-based analytical procedures.